| Gilead Sciences Switzerland Sàrl - Genvoya 150mg/150mg/200mg/10mg, Filmtabletten | | 65793 | | 01 | | Genvoya 150mg/150mg/200mg/10mg | | Filmtabletten | | J05AR18 | | Emtricitabine, Tenofovir Alafenamide, Elvitegravir and Cobicistat | | 01.09.2016 | | |
| | Composition | | elvitegravirum 150 mg, cobicistatum 150 mg, emtricitabinum 200 mg, tenofovirum alafenamidum 10 mg ut tenofoviri alafenamidi hemifumaras, lactosum monohydricum 60.8 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, natrii laurilsulfas, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 132, E 172 (flavum), pro compresso obducto corresp. natrium 7.155 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Cobicistatum | 150 mg | | Elvitegravirum | 150 mg | | Emtricitabine | 200 mg | | Tenofovirum Alafenamidum | 10 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Cobicistatum | 150 mg | | Elvitegravirum | 150 mg | | Emtricitabine | 200 mg | | Tenofovirum Alafenamidum | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Lactose Monohydrate | 60.8 mg | | | Macrogol | | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | 1070.40 | 1180.55 | A | LS | Oui |
|
|
